A U.S. Perspective on Global Strategy
Biosimilars Around the World
Last month’s Supreme Court ruling in Sandoz v. Amgen brought greater certainty to both biosimilar applicants and originators in the United States. The July 2017 issue of Sterne Kessler’s Global Patent Prosecution Newsletter includes information on worldwide biosimilar approvals and their global uptake, with a focus on the US, Europe, and Japan.
In this issue:
- You Can Dance if You Want to
- Biosimilars in Europe
- Biosimilar Uptake and Patent Litigation in Japan
- Approved Biosimilar Products Around the World